Playlist

Mpox in the Democratic Republic of Congo (DRC): Early History

by Jean-Jacques Muyembe-Tamfum, MD, PhD

My Notes
  • Required.
Save Cancel
    Learning Material 2
    • PDF
      Slides Mpox-in-the-Democratic-Republic-of-Congo-DRC-Early-History.pdf
    • PDF
      Download Lecture Overview
    Report mistake
    Transcript

    00:01 Good afternoon. I would like to share with you the history of human MPOX, formerly monkeypox in the Democratic Republic of Congo.

    00:16 The history of this disease is linked with the global eradication of smallpox between 1960 and 1965. At that time, all the countries surrounding DRC were free of smallpox except South Sudan.

    00:49 So, we had in DRC sometime 3000 cases of smallpox per year. You.

    01:02 It is why DRC , together with WHO started the campaign against for variola vaccination. At that time we observed in DRC two types of variola, called also smallpox.

    01:26 Both variola major and variola minor were circulating in DRC.

    01:35 With case fatality rate between 5% and 15%. After independence, the reporting was irregular. Only variola major was documented, and major outbreaks occur in Kasai, Equateur and Katanga provinces.

    01:59 The capital, Kinshasa, experienced a very, very important, outbreak of smallpox with more than 200 deaths.

    02:14 So we we need ten months to control this outbreak.

    02:21 The context in the region was that, the transmission was interrupted in neighboring countries, except South Sudan, as I said. And we can retain key dates. Uh, in 1970, this was the first human monkeypox detected in the world that was in the Basankusu, uh, District Equatorial Province, and in 1977 smallpox was eradicated in DRC. The main events of MPOX are as follows. As I said, in 1970, the first case of MPOX was identified in Basankusu District, and in 1976 it was the first Ebola outbreak in Congo in Yambuku. And in 1977 we received a certification of the eradication of smallpox in DR Congo, and in 1980 WHO/AFRO program for integrated surveillance of MPOX and viral hemorrhagic fever, global cessation of smallpox vaccination.

    04:06 So the most important thing to know now is the global cessation of smallpox vaccination in 1980.

    04:15 And between 1981 and 1986, the WHO and the Minister of Health introduced the intense and active surveillance of MPOX in Africa, and in 1986, this program was stopped and the surveillance activities for monkeypox were also stopped. But in 1996 1997 there was a reemergence of a large outbreak of MPOX, affecting 54 villages in the Catacomb Health Zone district of Sankuru, and the impulse was included on the national list of notifiable diseases and in 2001 INRB, the Institut National de Recherche Biomédicale established international research partnership with WHO, CDC, Institute of Tropical Medicine for MPOX studies.

    05:23 So this is the the first case of MPOX in a seven year old child in Democratic Republic of Congo.

    05:34 This is the photo of WHO.

    05:39 And here we see the physical, the lesion caused by, uh, these, uh, these diseases. So the first human MPOX case was detected in 1970, in a rural DRC during the smallpox eradication campaign, the discovery of this new disease was considered a serious threat to the global Smallpox Eradication Program. The transmission of the disease was by contact with the infected rodent or monkeys, or with a patient. So the first mode of transmission is with the contact with a wild animals, while infected animals like rodents. And the incidence of the disease was very high among children and non-smallpox -vaccinated adult.

    06:58 This I want to show you in this light, the status of MPOX in Africa in 1970 -1986. So at that time the the incidence of the disease was very low and WHO promised to pay anyone who discovers and report a case of monkeypox. That is confirmed by laboratory testing. A reward of 500 Zaire at that time is mean $1,000, because the disease was rare.

    07:55 And this reward was translated in a in a in local languages and distributed everywhere in the country. So between 1970 and 1980, only 59 cases were detected by passive surveillance despite this reward given by the WHO.

    08:26 Between 1981 -1986, 345 cases were detected/reported by active surveillance.

    08:41 This was the program established by WHO and the Ministry of Health, and 90% of MPOX cases in Africa were reported by DRC. So as you can see, our seven African countries were affected.

    09:05 We have the Cameroon, Central African Republic, Ivory Coast, Liberia, Nigeria, Sierra Leone and DRC. So between 1970 and 1979, very few cases were reported.

    09:23 But between 1980 and 1986, because of the active surveillance, the number of cases detected were more than 300, but 95% of all cases were reported by DRC. Okay, so after this active surveillance that was organized between 1981 -1986.

    09:56 The question was, is that a threat to global smallpox eradication program achievement? So the answer of the WHO team of MPOX intensified surveillance program, organized between 1981 -1986, in DRC, was no. Because MPOX was a sporadic disease and majority of cases resulted from animal to to human transmission.

    10:36 So person to person transmission was rather difficult and the secondary attack rate was low.

    10:47 We have no transmission beyond the fourth round of transmission. The WHO team conclusion was that MPOX is not a public health concern.

    11:01 The WHO active surveillance program was then stopped. This is the team, and I was a member of of this team.

    11:14 I was still young there at that time.


    About the Lecture

    The lecture Mpox in the Democratic Republic of Congo (DRC): Early History by Jean-Jacques Muyembe-Tamfum, MD, PhD is from the course Mpox (Monkeypox): Insights and Challenges.


    Included Quiz Questions

    1. In 1970 in Basankusu, Equatorial Province of the Democratic Republic of Congo
    2. In 1976 in Yambuku, Democratic Republic of Congo
    3. In 1977 when smallpox was eradicated in the Democratic Republic of Congo
    4. In 1980 when the WHO surveillance program began
    5. In 1996 during the reemergence in Kasai Province
    1. The global smallpox eradication campaign
    2. The WHO integrated surveillance program
    3. The Ebola virus containment program
    4. The polio vaccination campaign
    5. The viral hemorrhagic fever surveillance system
    1. Animal-to-human transmission
    2. Human-to-human transmission
    3. Airborne transmission in hospital settings
    4. Vector-borne transmission through mosquitoes
    5. Contact with contaminated medical equipment
    1. 345 cases were detected by active surveillance compared to 59 cases during passive surveillance
    2. No significant difference in detection rates was observed between the methods
    3. Passive surveillance detected more cases than active surveillance
    4. Active surveillance programs failed to detect any new cases
    5. Active surveillance was only implemented in one province, limiting its effectiveness
    1. Mpox was not a public health concern as it was a sporadic disease with limited person-to-person transmission
    2. Mpox represented a significant threat to the smallpox eradication achievement
    3. Mpox required continued global vaccination programs similar to smallpox
    4. Mpox surveillance should be expanded to all countries in Central Africa
    5. Mpox would likely cause major urban outbreaks within the next decade

    Author of lecture Mpox in the Democratic Republic of Congo (DRC): Early History

     Jean-Jacques Muyembe-Tamfum, MD, PhD

    Jean-Jacques Muyembe-Tamfum, MD, PhD


    Customer reviews

    (1)
    5,0 of 5 stars
    5 Stars
    5
    4 Stars
    0
    3 Stars
    0
    2 Stars
    0
    1  Star
    0